Are you Dr. Lai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 93 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Medical Plz
Suite B200
Los Angeles, CA 90095Phone+1 310-794-1195Fax+1 310-794-7491
Summary
- Dr. Albert Lai, MD is a board certified neurologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Ronald Reagan UCLA Medical Center and is an Assistant Professor at UCLA School of Medicine.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2002 - 2005
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1999 - 2002
- Adventist Health White MemorialInternship, Internal Medicine, 1998 - 1999
- University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2011 Oct 03
- Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.Nicholas S Cho, Francesco Sanvito, Viên Lam Le, Sonoko Oshima, Ashley Teraishi
Neuroradiology. 2024-12-01 - Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors.Nicholas S Cho, Viên Lam Le, Francesco Sanvito, Sonoko Oshima, Jayla Harper
Neuro-Oncology. 2024-10-03 - Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma.Nicholas S Cho, Chencai Wang, Kathleen Van Dyk, Francesco Sanvito, Sonoko Oshima
AJNR. American Journal of Neuroradiology. 2024-10-03
Press Mentions
- Preferential Tumor Localization in Relation to 18F-FDOPA Uptake for Lower‐Grade GliomasMarch 11th, 2021
- Relative Oxygen Extraction Fraction (rOEF) MR Imaging Reveals Higher Hypoxia in Human Epidermal Growth Factor Receptor (EGFR) Amplified Compared with Non-Amplified GliomasOctober 26th, 2020
- Impact of Dementia Risk Factors May Vary by Race and Ethnicity, Study FindsOctober 19th, 2023